SALE
市場調查報告書
商品編碼
1021832

婦產科用醫藥品的市場預測、競爭趨勢、成長機會 (∼2026年): 治療方法、適應症、通路、各地區

Global Gynecology Drugs Market, By Therapeutics, By Indication, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球婦產科用醫藥品的市場規模從2020年的133億4323萬美元,在預測期間中預計以7.42%的年複合成長率成長。

婦產科系的癌症與其他疾病的劇增促進該市場的成長。

本報告提供全球婦產科用醫藥品的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析、 客戶的迴響分析,市場規模的變化、預測,各治療方法、適應症、銷售管道的明細,各地區、主要國家的詳細分析,競爭環境,主要企業簡介等彙整資訊。

第1章 產品概要

第2章 調查手法

第3章 COVID-19的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療法
      • 荷爾蒙療法
      • 非荷爾蒙療法
    • 各適應症
      • 婦產科癌症
      • 多囊性卵巢症候群
      • 避孕
      • 子宮內膜異位症
      • 女性不孕症
      • 婦產科感染疾病
      • 停經後障礙
    • 各銷售管道
      • 醫院藥局
      • 零售藥局
      • 線上藥局
    • 各企業
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東、非洲
  • 產品市場地圖

第7章 北美市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療
    • 各適應症
    • 各銷售管道
    • 各國
  • 各國分析

第8章 歐洲市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療
    • 各適應症
    • 各銷售管道
    • 各國
  • 各國分析

第9章 亞太地區市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療
    • 各適應症
    • 各銷售管道
    • 各國
  • 各國分析

第10章 南美市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療
    • 各適應症
    • 各銷售管道
    • 各國
  • 各國分析

第11章 中東、非洲市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各治療
    • 各適應症
    • 各銷售管道
    • 各國
  • 各國分析

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭預測
  • 主要企業的簡介
    • Amgen Inc.
    • F. Hoffmann-La Roche Ltd.
    • Novartis Ltd.
    • Bayer AG
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc
    • Sanofi SA
    • Eli Lilly and Company Ltd.
    • Ferring Pharmaceuticals A/S
    • AstraZeneca Plc
    • TherapeuticsMD, Inc.
    • AbbVie Inc.
    • Abbott Laboratories Ltd.
    • Lupin Pharmaceuticals, Inc.
    • Pfizer Inc.

第15章 策略性建議

第16章 關於本公司、免責聲明

目錄
Product Code: 7427

Global gynecology drugs market was valued at USD13343.23 million in 2020 and is anticipated to grow at a CAGR of 7.42% in the forecast years, 2022-2026, on account of rapidly increasing instances of gynecology cancer and other gynecology disorders. These diseases have increased the fatality rate of the women population in the last five years. Thus, the government is now working on creating awareness and alerting the women population towards keeping check on their personal wellbeing and gynae health issues. These inferences are anticipated to substantiate the growth of the market in the forecast years. Moreover, lifestyle changes among women are also expected to drive the market growth. With increasing number of working women and their employment into various industries, the chances of infection and diseases due to prolonged exposure to harmful chemicals and toxins would positively influence the growth of the global gynecology drugs market.

Gynecology drugs are therapeutics and biologics that are administered for the treatment of gynecology disorders and ailments to the women patient. Gynecology disorders affect the reproductive system of the females and causes infection, or functional failure in the parts like uterus, urinary bladder, urethra, ovaries, appendages, etc. Recent developments in the gynecology therapeutics and technologically advanced devices for the early diagnosis of gynecology disorders are expected to drive the growth of the market in the next five years.

The global gynecology drugs market is segmented on the basis of therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on therapeutics, the market is further bifurcated into hormonal therapy and non-hormonal therapy. Moreover, rapid advancements in new product development are supporting the growth of the market in the next five years. Hormonal therapy is also expected to hold the significant share of the market owing to the rising demand for new technologically advanced medicine, although the therapy has certain side effects such as the risk of breast cancer. Based on distribution channel, the market is segregated into hospital pharmacies, retail pharmacies and online pharmacies. The online pharmacies segment is anticipated to lead the market in the forecast period, 2022-2026.

Major companies in the market are Amgen Inc., F. Hoffmann-La Roche Ltd., Novartis Ltd., Bayer AG, Merck & Co., Inc., GlaxoSmithKline Plc, Sanofi SA, Eli Lilly and Company Ltd., Ferring Pharmaceuticals A/S, AstraZeneca Plc, TherapeuticsMD, Inc., AbbVie Inc., Abbott Laboratories Ltd., Lupin Pharmaceuticals, Inc., Pfizer Inc., among others. The market players are actively involved in the technological advancements of the therapeutics as well as research and development of the medical devices used for the administration of the gynecology drugs.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

1. To analyze the historical growth in the market size of global gynecology drugs market from 2016 to 2020.

2. To estimate and forecast the market size of global gynecology drugs market from 2021 to 2026 and growth rate until 2026.

3. To classify and forecast global gynecology drugs market based on therapeutics, indication, distribution channel, regional distribution, and competitive landscape.

4. To identify dominant region or segment in the global gynecology drugs market.

5. To identify drivers and challenges for global gynecology drugs market.

6. To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global gynecology drugs market.

7. To identify and analyze the profile of leading players operating in global gynecology drugs market.

8. To identify key sustainable strategies adopted by market players in global gynecology drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global gynecology drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and indications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

1. Manufacturers, end users, and other stakeholders

2. Distributors and suppliers of gynecology and other stakeholders

3. Organizations, forums, and alliances related to gynecology drugs

4. Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Gynecology Drugs Market, By Therapeutics:
  • Hormonal Therapy
  • Non-Hormonal Therapy
  • Global Gynecology Drugs Market, By Indication:
  • Gynecology Cancers
  • Polycystic Ovary Syndrome
  • Contraception
  • Endometriosis
  • Female Infertility
  • Gynecology Infections
  • Postmenopausal Disorders
  • Global Gynecology Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Gynecology Drugs Market, By Region:
  • North America

i. United States

ii. Canada

iii. Mexico

  • Europe

i. Germany

ii. France

iii. United Kingdom

iv. Italy

v. Spain

  • Asia-Pacific

i. China

ii. Japan

iii. India

iv. Australia

v. South Korea

  • South America

i. Brazil

ii. Argentina

iii. Colombia

  • Middle East & Africa

i. South Africa

ii. Saudi Arabia

iii. UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Gynecology Drugs Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Factors Influencing Purchase Decision of the Drug
  • 5.3. Patient Satisfaction Analysis

6. Global Gynecology Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy)
    • 6.2.2. By Indication (Gynecology Cancers, Polycystic Ovary Syndrome, Contraception, Endometriosis, Female Infertility, Gynecology Infections, Postmenopausal Disorders)
    • 6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 6.2.4. By Company (2020)
    • 6.2.5. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
  • 6.3. Product Market Map

7. North America Gynecology Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapeutics
    • 7.2.2. By Indication
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Gynecology Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapeutics
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Canada Gynecology Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapeutics
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Mexico Gynecology Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapeutics
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Distribution Channel

8. Europe Gynecology Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutics
    • 8.2.2. By Indication
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country (Germany; France; United Kingdom; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Gynecology Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapeutics
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. France Gynecology Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapeutics
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. United Kingdom Gynecology Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapeutics
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Italy Gynecology Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapeutics
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Spain Gynecology Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapeutics
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Distribution Channel

9. Asia-Pacific Gynecology Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutics
    • 9.2.2. By Indication
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country (China; Japan; India; Australia; South Korea)
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Gynecology Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutics
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Japan Gynecology Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutics
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. India Gynecology Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutics
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Distribution Channel
    • 9.3.4. Australia Gynecology Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapeutics
        • 9.3.4.2.2. By Indication
        • 9.3.4.2.3. By Distribution Channel
    • 9.3.5. South Korea Gynecology Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapeutics
        • 9.3.5.2.2. By Indication
        • 9.3.5.2.3. By Distribution Channel

10. South America Gynecology Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutics
    • 10.2.2. By Indication
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country (Brazil; Argentina; Colombia)
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gynecology Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutics
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Argentina Gynecology Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutics
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Colombia Gynecology Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutics
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Gynecology Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutics
    • 11.2.2. By Indication
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country (South Africa; Saudi Arabia ; UAE)
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Gynecology Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutics
        • 11.3.1.2.2. By Indication
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutics
        • 11.3.2.2.2. By Indication
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. UAE Gynecology Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutics
        • 11.3.3.2.2. By Indication
        • 11.3.3.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Global Players Profiled (Leading Companies)
    • 14.2.1. Amgen Inc.
    • 14.2.2. F. Hoffmann-La Roche Ltd.
    • 14.2.3. Novartis Ltd.
    • 14.2.4. Bayer AG
    • 14.2.5. Merck & Co., Inc.
    • 14.2.6. GlaxoSmithKline Plc
    • 14.2.7. Sanofi SA
    • 14.2.8. Eli Lilly and Company Ltd.
    • 14.2.9. Ferring Pharmaceuticals A/S
    • 14.2.10. AstraZeneca Plc
    • 14.2.11. TherapeuticsMD, Inc.
    • 14.2.12. AbbVie Inc.
    • 14.2.13. Abbott Laboratories Ltd.
    • 14.2.14. Lupin Pharmaceuticals, Inc.
    • 14.2.15. Pfizer Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 5: Global Gynecology Drugs Market Share, By Company, By Value, 2020
  • Figure 6: Global Gynecology Drugs Market Share, By Region, By Value, 2016-2026F
  • Figure 7: Global Gynecology Drugs Product Market Map, By Value, 2016-2026F
  • Figure 8: North America Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 9: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 10: North America Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 11: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 12: North America Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 13: United States Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 14: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 15: United States Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 16: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 17: Canada Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 18: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 19: Canada Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 20: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 21: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 22: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 23: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 24: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 25: Europe Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 26: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 27: Europe Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 28: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 29: Europe Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 30: Germany Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 31: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 32: Germany Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 33: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 34: France Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 35: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 36: France Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 37: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 38: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 39: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 40: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 41: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 42: Italy Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 43: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 44: Italy Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 45: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 46: Spain Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 47: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 48: Spain Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 49: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 50: APAC Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 51: APAC Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 52: APAC Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 53: APAC Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 54: APAC Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 55: China Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 56: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 57: China Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 58: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 59: Japan Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 60: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 61: Japan Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 62: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 63: India Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 64: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 65: India Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 66: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 67: Australia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 68: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 69: Australia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 70: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 71: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 72: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 73: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 74: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 75: South America Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 76: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 77: South America Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 78: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 79: South America Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 80: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 81: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 82: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 83: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 84: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 85: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 86: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 87: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 88: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 89: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 90: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 91: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 92: MEA Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 93: MEA Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 94: MEA Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 95: MEA Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 96: MEA Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
  • Figure 97: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 98: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 99: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 100: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 101: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 102: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 103: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 104: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 105: UAE Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 106: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
  • Figure 107: UAE Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
  • Figure 108: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F